The Nutritional Status of Chemo-radiotherapy Patients

Cancer Clinical Trial

— PANSOCRP  

Official title:

Prospective Analysis of the Nutritional Status of Chemo-radiotherapy Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01937273
• Other study ID #: HREC2013 1973
• Status: Completed
• Start date: June 2013
• Est. completion date: December 2015

Study information

• Verified date: July 2020
• Source: Charles Darwin University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Cancer patients are one of the patient groups at highest risk for the development of malnutrition. Anti-cancer treatments, such as chemotherapy and radiotherapy, can further heighten the risk due to the nutrition-related toxicities experienced during this time.

This study aims to baseline the nutritional status of chemo-radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), identify contributors to nutritional deterioration and determine if there is a difference between Indigenous and non-Indigenous patients.

Description:

Background: Cancer patients are at a greater risk of malnutrition. Limited data exists on the development of malnutrition during chemo - radiotherapy, particularly in rural and remote areas of Australia. Additionally, there is no data on the nutritional status of cancer patients in the Northern Territory or areas with a high proportion of Indigenous Australians. While considering the aforementioned dearth of literature, we are conducting a study in Darwin, Northern Territory of Australia. This study aims to establish a baseline of the nutritional status of chemo - radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), to identify contributing factors to nutritional deterioration, and to determine if there is a difference between Indigenous and non-Indigenous patients. This study will provide a prospective analysis of malnutrition and a clear insight of nutritional status of cancer patients. It presents the first of its kind to address the nutritional status of cancer patients in Indigenous Australians.

Methods/ design: Using the Patient Generated-Subjective Global Assessment; all eligible patients will be assessed for malnutrition and consented for participation into this study. Each participant's nutritional status will be assessed at baseline, first week of treatment, final week of treatment, and at one month post treatment. Prevalence data will be analysed using percentages. Comparative data will be analysed using chi-square tests. A linear regression analysis of the results will be undertaken. Data will be analysed using SPSS version 20 (IBM SPSS).

Discussion: Weight loss and malnutrition among cancer patient is well documented, however, results from our study might appear to be more remarkable when compared with the other published data, because of our participants demographic, assessment tool used: the Patient Generated-Subjective Global Assessment has not been validated for use in Indigenous Australian Keywords: Nutritional status, malnutrition, prospective analysis, chemo-radiotherapy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or over undergoing curative intent chemo-radiotherapy at AWCCC

• Able to speak basic English or have an interpreter present

• Able to provide consent

Exclusion Criteria:

• Pregnant or breast feeding women

• Non-English speaking background where interpreter not available

• Change to single modality treatment (ie change from chemo-radiotherapy to chemotherapy or radiotherapy alone) or change to treatment intent (ie change from curative intent to palliative intent)

• Violent or aggressive patients to maintain the safety of investigators

Related Conditions & MeSH terms

• Cancer
• Malnutrition

Locations

Country	Name	City	State
Australia	Alan Walker Cancer Care Centre	Darwin	Northern Territory

Sponsors (1)

Lead Sponsor	Collaborator
Charles Darwin University

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Factors contributing to the development of malnutrition		1 year
Other	The difference between Indigenous and non-Indigenous in respect to their nutritional status		1 year
Primary	The prevalence of malnutrition amongst chemo-radiotherapy patients		1 year
Secondary	The incidence of the development of malnutrition during chemo-radiotherapy		1 year